A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: Short- and long-term outcomes

Journal of the American Academy of Dermatology

Volumn 55, Issue 4, 2006, Pages 637-641

  Koo, John ^a   Blum, Robin R ^b   Lebwohl, Mark ^b  

^a UCSF Psoriasis   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CLOBETASOL PROPIONATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG PULSE THERAPY; FEMALE; FOAM; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OINTMENT; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; CALCITRIOL; CLOBETASOL; DOSAGE FORMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; OINTMENTS; PSORIASIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748923950     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.05.026     Document Type: Article

References (13)

1. Koo J. Systemic sequential therapy of psoriasis: a new paradigm for improved therapeutic results. J Am Acad Dermatol 41 Suppl 2 (1999) S25-S28
2. Koo J.Y.M. How and why to use sequential therapy for psoriasis. Skin Aging 6 (1998) 42-46
3. Lebwohl M., Siskin S., Epinette W., Breneman D., Funicella T., Kalb R., et al. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol 35 (1996) 268-269
4. Lebwohl M., Yoles A., Lombardi K., and Lou W. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. J Am Acad Dermatol 39 (1998) 447-450
5. Patel B., Siskin S., Krazmien R., and Lebwohl M. Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol 38 (1998) 1010-1011
6. Lamba S., and Lebwohl M. Combination therapy with vitamin D analogues. Br J Dermatol 144 Suppl 58 (2001) 27-32
7. Olux Product Label. Connetics Corporation. Palo Alto, Calif, 2004.
8. Lenn J, Tanojo H, Huang X. Anatomical region variations on the in vitro skin permeation of clobetasol propionate formulations. Presented at: 62nd Annual Meeting of the American Academy of Dermatology, February 6-11, 2004, Washington, DC.
9. Lenn J, Madlambayan L, Huang X, Tanojo H. Comparison of clobetasol propionate skin permeation and drug distribution in vitro from various topical drug delivery vehicles (foam, lotion, and wash-off shampoo). Presented at: Summer Meeting of the American Academy of Dermatology, July 29- August 1, 2004, New York, NY.
10. Deng H, Tanojo H, Lenn J, Cuesico C, Huang X. Foam as a novel vehicle in topical therapy. Presented at: 62nd Annual Meeting of the American Academy of Dermatology, February 6-11, 2004, Washington, DC.
11. Huang X, Tanojo H, Lenn J, Cuesico C, Deng H. Impact of vehicle on clobetasol propionate skin permeation and drug distribution in vitro. Presented at: 62nd Annual Meeting of the American Academy of Dermatology, February 6-11, 2004, Washington, DC.
12. Little R.C., Milliken G.A., Stroup W.W., and Wolfinger R.D. SAS system for mixed models (1996), SAS Institute, Cary (NC)
13. Stokes M.E., Davis C.S., and Koch G.G. Categorical data analysis using the SAS system (2000), SAS Institute, Cary (NC) pp. 428-70